CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Feb. 01, 2014	Feb. 02, 2013	Jan. 28, 2012
Cash flows from operating activities:
Net income	$ 26,015	$ 29,629	$ 33,428
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	41,047	39,541	34,190
Net (gain) loss on asset disposition	(3,972)	(471)	(2,761)
Provision (recovery) for store closures and asset impairment	1,700	(67)	112
Stock-based compensation	1,791	2,055	2,075
Provision (recovery) for uncollectible receivables	103	(106)	447
LIFO reserve increase	4,526	3,937	2,792
Deferred income tax (benefit) expense	(5,165)	(583)	6,462
Income tax (charge) benefit upon exercise of stock options	(23)	30	27
Benefit for postretirement medical	(82)	(91)	(85)
(Increase) decrease in operating assets:
Trade and non-trade receivables	(3,596)	(7,490)	(8,313)
Insurance receivables	298	(273)	205
Inventories	(14,953)	(25,254)	(21,402)
Other assets	(111)	(615)	607
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses	11,218	8,068	25,464
Income taxes payable	(921)	2,627	(1,719)
Other noncurrent liabilities	986	(6,187)	1,801
Net cash provided by operating activities	58,861	44,750	73,330
Cash flows from investing activities:
Capital expenditures	(25,918)	(27,391)	(45,681)
Proceeds from asset dispositions	6,267	1,593	3,354
Insurance recoveries for replacement assets	176	0	0
Asset acquisitions, net (primarily intangibles)	(25,066)	(20,203)	(16,770)
Net cash used in investing activities	(44,541)	(46,001)	(59,097)
Cash flows from financing activities:
Payments of indebtedness and capital lease obligations	(1,308)	(693)	(514)
Proceeds from revolving line of credit	235,270	78,444	0
Payments on revolving line of credit	(242,247)	(71,547)	0
Excess tax benefit (charges) from stock-based compensation	23	(30)	(27)
Proceeds from exercise of stock options and employee stock purchase plan	1,368	1,109	451
Repurchase of shares	0	(9,176)	(28,482)
Cash dividends paid	(8,830)	(15,857)	(7,713)
Net cash used in financing activities	(15,724)	(17,750)	(36,285)
Decrease in cash and cash equivalents	(1,404)	(19,001)	(22,052)
Cash and cash equivalents:
Beginning of year	8,129	27,130	49,182
End of year	6,725	8,129	27,130
Supplemental disclosures of cash flow information:
Interest paid	487	549	397
Income taxes paid	19,831	15,447	13,126
Non-cash investing and financial activities:
Assets acquired through term loan	0	0	3,497
Restricted stock issued for the aquistion of intangible assets	$ 0	$ 0	$ 135